Search results with tag "Drug and biologic"

COVID-19 Drug and Biologic Therapeutics - Cigna

static.cigna.com

Page 2 of 60 Drug and Biologic Coverage Policy: 2016 Sotrovimab Tixagevimab and Cilgavimab (EVUSHELD™) Tocilizumab intravenous (Actemra IV ®) EUA / Non-EUA Tofacitinib (Xeljanz ®/Xeljanz XR ®) The use of intravenous tocilizumab for non-COVID-19 uses is addressed in a separate coverage policy.

Policy, Drug, Biologics, Drug and biologic

Similar queries

Drug and Biologic, Policy